EVAX
Evaxion AS
NASDAQ · Healthcare · Biotechnology · DK
$3.27
+1.55%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.01
- Revenue estimate
- $300.0K
Latest reported
- Last report date
- Aug 20, 2026
- EPS actual
- -$0.01
- EPS estimate
- -$0.01
- Revenue actual
- —
- Revenue estimate
- $6.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -1074.2%
- Revenue beats (12Q)
- 3
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 20, 2026 | -$0.01 | -$0.01 | In line | — |
| May 7, 2026 | -$0.01 | -$0.44 | Miss -4300.00% | — |
| Mar 5, 2026 | — | -$1.00 | — | — |
| Nov 6, 2025 | — | $0.73 | — | $7.5M |
| Aug 14, 2025 | -$0.50 | -$0.76 | Miss -52.00% | — |
| May 27, 2025 | -$0.65 | -$0.29 | Beat 55.38% | — |
| Mar 26, 2025 | -$0.26 | -$0.80 | Miss -207.69% | $122.0K |
| Oct 31, 2024 | -$0.60 | -$0.20 | Beat 66.67% | $3.0M |
| Aug 14, 2024 | $0.10 | -$0.60 | Miss -700.00% | $153.9K |
| May 28, 2024 | -$0.56 | $0.15 | Beat 126.79% | $50.9K |
| Dec 19, 2023 | -$0.19 | -$11 | Miss -5426.32% | — |
| Aug 18, 2023 | -$0.21 | -$11 | Miss -4900.00% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026